Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Migraine

  Free Subscription


20.10.2025

1 BMC Neurol
3 Cephalalgia
6 Headache
1 Neurologia (Engl Ed)
2 Neurology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. CARDONA-ROCA L, Segui-Solanes C, Cano-Alonso M, Sosa-Pons A, et al
    Impact of anti-CGRP monoclonal antibodies on treatment satisfaction and quality of life in patients with resistant migraine: a retrospective real-world study.
    BMC Neurol. 2025;25:418.
    PubMed         Abstract available


    Cephalalgia

  2. TAMAYO DE LEON CD, Gama-Reyes EG, Paredes Moreno FA, Galnares-Olalde JA, et al
    Adjunctive occipital nerve block for emergency treatment of acute migraine: A randomized, controlled trial.
    Cephalalgia. 2025;45:3331024251381764.
    PubMed         Abstract available

  3. YU S, Matsumori Y, Kim BK, Gryglas-Dworak A, et al
    Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial.
    Cephalalgia. 2025;45:3331024251386095.
    PubMed         Abstract available

  4. POZO-ROSICH P, Blumenfeld AM, Lipton RB, DeGryse RE, et al
    OnabotulinumtoxinA for the preventive treatment of episodic migraine: Results from the phase 3, multicenter randomized, double-blind, placebo-controlled phase of the PRECLUDE trial.
    Cephalalgia. 2025;45:3331024251370769.
    PubMed         Abstract available


    Headache

  5. QAISER S, Shady K
    Serum magnesium levels in children and adolescents with migraine: A prospective observational study.
    Headache. 2025 Oct 16. doi: 10.1111/head.15081.
    PubMed        

  6. NAHAS SJ, Birlea M, Stark-Inbar A, Shmuely S, et al
    Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon.
    Headache. 2025 Oct 16. doi: 10.1111/head.15069.
    PubMed         Abstract available

  7. GRODZKA O, Boronczyk M, Zdunska A, Wegrzynek-Gallina J, et al
    Migraine and patent foramen ovale: correlation, coexistence, dependence. A narrative review.
    Headache. 2025 Oct 15. doi: 10.1111/head.15067.
    PubMed         Abstract available

  8. PERIS-SUBIZA J, Obach V, Guisado-Alonso D, Velasco Juanes F, et al
    Effectiveness and tolerability of galcanezumab for migraine prevention in patients >/=65 years: A real-life multicenter study.
    Headache. 2025 Oct 14. doi: 10.1111/head.15064.
    PubMed         Abstract available

  9. OGREZEANU DC, Nunez-Cortes R, Salazar-Mendez J, Cuyul-Vasquez I, et al
    How much aerobic exercise is needed to reduce migraine? A dose-response meta-analysis of pain intensity and frequency.
    Headache. 2025 Oct 14. doi: 10.1111/head.15070.
    PubMed         Abstract available

  10. PAIVA DA SILVA LIMA G, Rao R, Szabo G, Szklener S, et al
    Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.
    Headache. 2025 Oct 14. doi: 10.1111/head.15071.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  11. GOUFA E, Chentouf A, Belabbas S, Boughrara W, et al
    Impact of fasting during Ramadan on migraine in the Algerian population.
    Neurologia (Engl Ed). 2025;40:762-767.
    PubMed         Abstract available


    Neurology

  12. TU YH, Huang TC, Tzeng YS, Chen SP, et al
    Prevalence, Clinical Correlates, and Functional Implications of Vestibular Symptoms in Patients With Migraine.
    Neurology. 2025;105:e214248.
    PubMed         Abstract available

  13. JANG SI, Kim N, Han K, Lee MJ, et al
    Association Between Obesity and the Risk of Migraine: A Nationwide Cohort Study in South Korea.
    Neurology. 2025;105:e214252.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.